Healthy adult
Conditions
Interventions
Single ingestion of ornithine 2.4 g followed by single ingestion of placebo
Single ingestion of placebo followed by single ingestion of ornithine 2.4 g
Sponsors
Kirin Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Male subjects between 20 and 40 year of age at the time of consent 2)Subjects with regular exercise about once a week, less than six times a month 3)Non-smoker
Exclusion criteria
Exclusion criteria: 1)Subjects who regularly take ornithine supplements. 2)Subjects who aware perspire freely or modestly after moderate exercise. 3)Subjects who have illness under medical treatment. 4)Subjects who may possibly develop allergic reactions associated with the test products 5) Subjects who have critical disease history such as diabetes, hepatic disorder, kidney disorder, cardiac disorder. 6)Subjects who are considered inappropriate by the result of selection visit 7)Subjects who participate in another clinical study at the beginning of this study 8)Subjects who are judged not appropriate for this study by study physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood ammonia, transdermal secretion of ammonia | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose, lactate, urea nitrogen, lactate dehydrogenase, creatine phosphokinase | — |
Countries
Japan
Contacts
Public ContactTakeshi Kokubo
Kirin Co., Ltd. Research laboratories for health science & food technologies
Outcome results
None listed